|
medpundit |
||
 |
 |
|
Friday, October 25, 2002This survey paints a bleak picture of the state of academic–industrial contracting. According to the results, very few centers included standard language in their contracts that guaranteed the investigators at a given center access to the primary data from the entire study. Without such a guarantee, the entities sponsoring the research can effectively implement a "divide and conquer" strategy that allows each group of investigators access to their own data, but makes analysis of all the data in a multicenter trial a virtual impossibility. The one encouraging piece of news is that nearly all centers incorporated into their contracts language that gives investigators the right to submit data from their own center for publication. ...As new ideas are brought from the bench to the bedside, there will be more translational clinical research. There will be unexpected toxic effects and poor results with treatment strategies that initially seem promising. It is not a failure of the research system when such unexpected events occur. Rather, it is a failure of the system when a summons to court or the threat of being fired silences the voice of an investigator posted by Sydney on 10/25/2002 06:30:00 AM 0 comments 0 Comments: |
|
